marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Fulcrum Therapeutics Financial Ratios 2011-2024 | FULC
Annual Financial Ratios Fulcrum Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -0.0 | -4.6 | -4.6 | - | - | - | - | - | - | - | - |
P/S |
0.2 | 0.0 | 0.0 | 37.1 | - | - | - | - | - | - | - | - | - |
EPS |
-1.6 | -2.4 | -2.3 | - | - | -31.1 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
-2.42 M | -7.14 M | -11.3 M | 305 M | 304 M | 9.77 M | 3.02 M | - | - | - | - | - | - |
EBITDA per Share |
-1.77 K | -2.45 K | -2.22 K | -2.48 | -3.63 | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.1 | -3.6 | -1.2 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.2 | -0.01 | - | - | - | - | - | - | - | - | ||
P/B |
0.0 | 0.0 | 0.0 | 3.4 | 4.3 | - | - | - | - | - | - | - | - |
P/CF |
-0.0 | -0.0 | -0.0 | -6.1 | -9.5 | - | - | - | - | - | - | - | - |
ROE % |
-41.39 | -55.23 | -38.22 | -74.40 | -94.86 | - | - | - | - | - | - | - | - |
ROA % |
-37.77 | -48.47 | -34.40 | -54.65 | -74.86 | - | - | - | - | - | - | - | - |
ROCE % |
-47.05 | -56.58 | -38.32 | -75.24 | -96.63 | - | - | - | - | - | - | - | - |
Current Ratio |
11.5 | 8.2 | 10.0 | 3.8 | 4.7 | - | - | - | - | - | - | - | - |
DSO |
166.8 | 38.1 | 6.2 | 5.9 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
166.8 | 38.1 | 6.2 | 5.9 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
166.8 | 38.1 | 6.2 | 5.9 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Fulcrum Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.35 | 0.89 | -0.43 | - | -0.39 | -0.38 | -0.41 | - | -0.51 | -0.83 | -0.64 | - | -0.57 | -0.6 | -0.54 | - | -0.7 | -0.66 | -0.81 | - | -0.97 | -9.21 | -24.29 | - | -8.08 | -7.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.4 | 0.85 | -474 | - | -0.44 | -0.43 | -458 | - | -514 | -820 | -626 | - | -551 | -582 | -0.52 | - | -682 | -642 | -804 | - | -928 | -7.27 K | -22.4 K | - | -6.5 K | -6.45 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-10.18 | -11.15 | -40.02 | -26.40 | -37.12 | -38.44 | -51.00 | -45.62 | -54.60 | -52.87 | -49.39 | -40.01 | -59.93 | -70.87 | -69.63 | -55.79 | -74.77 | -73.83 | -72.46 | -76.36 | -62.32 | -29.29 | -1.86 | 43.82 | 43.82 | 29.77 | 17.45 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-9.11 | -9.95 | -36.70 | -24.25 | -33.83 | -34.79 | -44.33 | -38.80 | -46.91 | -45.44 | -42.24 | -33.22 | -47.85 | -54.38 | -52.24 | -40.98 | -55.96 | -56.30 | -56.12 | -60.26 | -70.69 | -66.14 | -63.36 | -19.57 | -19.57 | -9.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-15.30 | -16.28 | -45.36 | -30.08 | -41.08 | -41.34 | -52.73 | -46.04 | -55.05 | -53.05 | -49.51 | -40.10 | -60.17 | -71.23 | -70.21 | -56.55 | -76.06 | -75.50 | -74.26 | -77.71 | -63.44 | -29.65 | -1.84 | 26.60 | 26.60 | 12.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
12.8 | 14.4 | 12.2 | 11.4 | 11.9 | 12.1 | 12.9 | 8.2 | 9.4 | 5.7 | 7.1 | 10.0 | 10.2 | 5.1 | 5.5 | 3.8 | 3.8 | 3.8 | 3.8 | 4.7 | 4.7 | 4.7 | 4.7 | 8.8 | 8.8 | 8.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | 1.3 | - | - | 151.1 | 133.7 | 311.9 | - | 31.9 | 19.4 | 15.5 | - | 3.2 | 2.8 | 2.6 | - | 8.7 | 8.0 | 17.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 1.3 | - | - | 151.1 | 133.7 | 311.9 | - | 31.9 | 19.4 | 15.5 | - | 3.2 | 2.8 | 2.6 | - | 8.7 | 8.0 | 17.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 1.3 | - | - | 151.1 | 133.7 | 311.9 | - | 31.9 | 19.4 | 15.5 | - | 3.2 | 2.8 | 2.6 | - | 8.7 | 8.0 | 17.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency